Latest filing published 28 Dec 2021 for Rapid Therapeutic Science Laboratories, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Sean Paul Berrier: trading record in brief
Sean Paul Berrier (chief executive) discloses dealings in Rapid Therapeutic Science Laboratories, Inc. to SEC (Form 4). The record holds 4 filings, for trades running from 22 December 2020 to 27 December 2021.
On the market, this insider has only sold: 3 sales, €940k in total. Since January 2021: no purchases and 3 sales on the market.
The latest filing, published on 28 December 2021, reports a transaction in Rapid Therapeutic Science Laboratories, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 41 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sean Paul Berrier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares@ €0.229650.0% of flowCommon StockSEC:0001393905-21-000548:0
1 of 1 declaration